Literature DB >> 32275822

Molecular Interactions of Pyrazine-Based Compounds to Proteins.

Martin Juhás1, Jan Zitko1.   

Abstract

Pyrazine-based compounds are of great importance in medicinal chemistry. Due to their heteroaromatic nature, they uniquely combine properties of heteroatoms (polar interactions) with the properties of aromatic moieties (nonpolar interactions). This review summarizes results of a systematic analysis of RCSB PDB database focused on important binding interactions of pyrazine-based ligands cocrystallized in protein targets. The most frequent interaction of pyrazine was hydrogen bond to pyrazine nitrogen atom as an acceptor, followed by weak hydrogen bond with pyrazine hydrogen as donor. We also identified intramolecular hydrogen bonds within pyrazine ligands, π-interactions, coordination to metal ions, and few halogen bonds in chloropyrazines. In many cases the binding mode of the pyrazine fragment was complex, involving a combination of several interactions. We conclude that pyrazine as a molecular fragment should not be perceived as a simple aromatic isostere but rather as a readily interacting moiety of drug-like molecules with high potential for interactions to proteins.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32275822     DOI: 10.1021/acs.jmedchem.9b02021

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

Review 1.  Pyrazine and Phenazine Heterocycles: Platforms for Total Synthesis and Drug Discovery.

Authors:  Robert W Huigens; Beau R Brummel; Srinivasarao Tenneti; Aaron T Garrison; Tao Xiao
Journal:  Molecules       Date:  2022-02-07       Impact factor: 4.411

2.  On Reuben G. Jones synthesis of 2-hydroxypyrazines.

Authors:  Pierre Legrand; Yves L Janin
Journal:  Beilstein J Org Chem       Date:  2022-07-29       Impact factor: 2.544

3.  Thiazolidin-4-Ones as Potential Antimicrobial Agents: Experimental and In Silico Evaluation.

Authors:  Christophe Tratrat; Anthi Petrou; Athina Geronikaki; Marija Ivanov; Marina Kostić; Marina Soković; Ioannis S Vizirianakis; Nikoleta F Theodoroula; Michelyne Haroun
Journal:  Molecules       Date:  2022-03-16       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.